Chemoinformaics analysis of 1,2,3,9-TETRAHYDROPYRROLO[2,1-B]QUINAZOLINE
| Molecular Weight | 172.231 | nRot | 0 |
| Heavy Atom Molecular Weight | 160.135 | nRig | 32 |
| Exact Molecular Weight | 172.1 | nRing | 3 |
| Solubility: LogS | -4.355 | nHRing | 2 |
| Solubility: LogP | 3.751 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 28.5715 |
| nHD | 0 | BPOL | 14.8885 |
| QED | 0.469 |
| Synth | 5.566 |
| Natural Product Likeliness | 3.234 |
| NR-PPAR-gamma | 0.958 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.997 |
| Pgp-sub | 0 |
| HIA | 0.022 |
| CACO-2 | -5.188 |
| MDCK | 0.0000268 |
| BBB | 0.989 |
| PPB | 0.917825 |
| VDSS | 1.867 |
| FU | 0.11899 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.543 |
| CYP2c19-inh | 0.439 |
| CYP2c19-sub | 0.776 |
| CYP2c9-inh | 0.497 |
| CYP2c9-sub | 0.028 |
| CYP2d6-inh | 0.063 |
| CYP2d6-sub | 0.101 |
| CYP3a4-inh | 0.801 |
| CYP3a4-sub | 0.745 |
| CL | 13.347 |
| T12 | 0.085 |
| hERG | 0.004 |
| Ames | 0.03 |
| ROA | 0.991 |
| SkinSen | 0.036 |
| Carcinogencity | 0.777 |
| EI | 0.42 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.851 |
| Antiviral | No |
| Prediction | 0.690762 |